Question to the Department for Business, Energy and Industrial Strategy:

To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment he has made of (a) when the not for profit price commitment made by AstraZeneca as part of the deal with Oxford University to develop a covid-19 vaccine will expire and (b) the effect of the expiration of that commitment on the affordability of that vaccine for the NHS.

The timings of the not for profit price commitment are for the two parties involved, AstraZeneca and the University of Oxford to agree.

The NHS is preparing for the initial deployment of a safe, effective COVID-19 vaccine as soon as possible.